{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:45:29Z","timestamp":1793418329580,"version":"4.5.0"},"reference-count":46,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30171070"],"award-info":[{"award-number":["30171070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30371632"],"award-info":[{"award-number":["30371632"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30772595"],"award-info":[{"award-number":["30772595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2025.2606434","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:07:20Z","timestamp":1767877640000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Discovery of novel N-(prop-2-yn-1-yl)-1,2,3,4-tetrahydronaphthalen-1-amine derivatives as MAO-B inhibitors for the treatment of Parkinson\u2019s disease"],"prefix":"10.1080","volume":"41","author":[{"given":"Ziwei","family":"Wang","sequence":"first","affiliation":[{"name":"Key Laboratory for Biochemistry and Molecular Pharmacology of Chongqing, Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biochemistry and Molecular Pharmacology of Chongqing, Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwan","family":"Yi","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biochemistry and Molecular Pharmacology of Chongqing, Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biochemistry and Molecular Pharmacology of Chongqing, Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwu","family":"Fu","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biochemistry and Molecular Pharmacology of Chongqing, Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yu","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biochemistry and Molecular Pharmacology of Chongqing, Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson\u2019s disease and the environment","volume":"10","author":"Ball N","year":"2019","unstructured":"Ball N, Teo W-P, Chandra S, Chapman J. Parkinson\u2019s disease and the environment. Front Neurol. 2019;10:218.","journal-title":"Front Neurol"},{"issue":"4","key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1474-4422(25)00033-X","article-title":"Advances in diagnosis, classification, and management of pain in Parkinson\u2019s disease","volume":"24","author":"Tinazzi M","year":"2025","unstructured":"Tinazzi M, Gandolfi M, Artusi CA, Bannister K, Rukavina K, Brefel-Courbon C, de Andrade DC, Perez-Lloret S, Mylius V. Advances in diagnosis, classification, and management of pain in Parkinson\u2019s disease. Lancet Neurol. 2025;24(4):331\u2013347.","journal-title":"Lancet Neurol"},{"issue":"2","key":"e_1_3_4_4_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrneurol.2015.249","article-title":"Evolving basic, pathological and clinical concepts in PD","volume":"12","author":"Kalia LV","year":"2016","unstructured":"Kalia LV, Lang AE. Evolving basic, pathological and clinical concepts in PD. Nat Rev Neurol. 2016;12(2):65\u201366.","journal-title":"Nat Rev Neurol"},{"issue":"23","key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1021\/acs.jmedchem.0c01663","article-title":"Computational fragment-based design facilitates discovery of potent and selective monoamine oxidase-B (MAO-B) inhibitor","volume":"63","author":"Jin C-F","year":"2020","unstructured":"Jin C-F, Wang Z-Z, Chen K-Z, Xu T-F, Hao G-F. Computational fragment-based design facilitates discovery of potent and selective monoamine oxidase-B (MAO-B) inhibitor. J Med Chem. 2020;63(23):15021\u201315036.","journal-title":"J Med Chem"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"115142","DOI":"10.1016\/j.ejmech.2023.115142","article-title":"Discovery of novel 2-hydroxyl-4-benzyloxybenzyl aniline derivatives as potential multifunctional agents for the treatment of Parkinson\u2019s disease","volume":"249","author":"Cao Z","year":"2023","unstructured":"Cao Z, Fu X, Wang X, Zhang T, Zhong L, Xia Q, Zhu J. Discovery of novel 2-hydroxyl-4-benzyloxybenzyl aniline derivatives as potential multifunctional agents for the treatment of Parkinson\u2019s disease. Eur J Med Chem. 2023;249:115142.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/brain\/awh290","article-title":"Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson\u2019s disease: implications for dyskinesias","volume":"127","author":"de la Fuente-Fern\u00e1ndez R","year":"2004","unstructured":"de la Fuente-Fern\u00e1ndez R, Sossi V, Huang Z, Furtado S, Lu J-Q, Calne DB, Ruth TJ, Stoessl AJ. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson\u2019s disease: implications for dyskinesias. Brain. 2004;127(Pt 12):2747\u20132754.","journal-title":"Brain"},{"issue":"4","key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00702-018-1952-7","article-title":"Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson\u2019s disease","volume":"126","author":"Finberg JPM.","year":"2019","unstructured":"Finberg JPM. Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson\u2019s disease. J Neural Transm (Vienna). 2019;126(4):433\u2013448.","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-018-1927-8","article-title":"Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy","volume":"125","author":"Shih JC.","year":"2018","unstructured":"Shih JC. Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy. J Neural Transm (Vienna). 2018;125(11):1553\u20131566.","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"e_1_3_4_10_1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/01616412.2021.1942408","article-title":"Switch from rasagiline to safinamide in fluctuating Parkinson\u2019s disease patients: a retrospective, pilot study","volume":"43","author":"Bianchini E","year":"2021","unstructured":"Bianchini E, Sforza M, Rinaldi D, Alborghetti M, De Carolis L, Della Gatta F, Pontieri FE. Switch from rasagiline to safinamide in fluctuating Parkinson\u2019s disease patients: a retrospective, pilot study. Neurol Res. 2021;43(11):950\u2013954.","journal-title":"Neurol Res"},{"issue":"3","key":"e_1_3_4_11_1","first-page":"127","article-title":"A preliminary open-label study of moclobemide treatment of pain disorder","volume":"37","author":"Pirildar S","year":"2003","unstructured":"Pirildar S, Sezgin U, Elbi H, Uyar M, Zileli B. A preliminary open-label study of moclobemide treatment of pain disorder. Psychopharmacol Bull. 2003;37(3):127\u2013134.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"131817","DOI":"10.1016\/j.molstruc.2021.131817","article-title":"Aldoxime-and hydroxy-functionalized chalcones as highly potent and selective monoamine oxidase-B inhibitors","volume":"1250","author":"Oh JM","year":"2022","unstructured":"Oh JM, Rangarajan TM, Chaudhary R, Gambacorta N, Nicolotti O, Kumar S, Mathew B, Kim H. Aldoxime-and hydroxy-functionalized chalcones as highly potent and selective monoamine oxidase-B inhibitors. J Mol Struct. 2022;1250:131817.","journal-title":"J Mol Struct"},{"issue":"7","key":"e_1_3_4_13_1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/ol026902h","article-title":"Highly efficient CuI-catalyzed coupling of aryl bromides with oxazolidinones using Buchwald\u2019s protocol: a short route to linezolid and toloxatone","volume":"5","author":"Mallesham B","year":"2003","unstructured":"Mallesham B, Rajesh BM, Reddy PR, Srinivas D, Trehan S. Highly efficient CuI-catalyzed coupling of aryl bromides with oxazolidinones using Buchwald\u2019s protocol: a short route to linezolid and toloxatone. Org Lett. 2003;5(7):963\u2013965.","journal-title":"Org Lett"},{"issue":"7","key":"e_1_3_4_14_1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/cmdc.201700589","article-title":"Synthesis, biological evaluation and molecular modeling studies of propargyl\u2010containing 2, 4, 6\u2010trisubstituted pyrimidine derivatives as potential anti\u2010parkinson agents","volume":"13","author":"Kumar B","year":"2018","unstructured":"Kumar B, Kumar M, Dwivedi AR, Kumar V. Synthesis, biological evaluation and molecular modeling studies of propargyl\u2010containing 2, 4, 6\u2010trisubstituted pyrimidine derivatives as potential anti\u2010parkinson agents. ChemMedChem. 2018;13(7):705\u2013712.","journal-title":"ChemMedChem"},{"key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2016.00340","article-title":"Inhibitors of MAO-A and MAO-B in psychiatry and neurology","volume":"7","author":"Finberg JP","year":"2016","unstructured":"Finberg JP, Rabey JM. Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol. 2016;7:340.","journal-title":"Front Pharmacol"},{"issue":"3","key":"e_1_3_4_16_1","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1021\/jm501722s","article-title":"Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson\u2019s disease","volume":"58","author":"Huleatt PB","year":"2015","unstructured":"Huleatt PB, Khoo ML, Chua YY, Tan TW, Liew RS, Balogh B, Deme R, G\u00f6l\u00f6ncs\u00e9r F, Magyar K, Sheela DP, et al. Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson\u2019s disease. J Med Chem. 2015;58(3):1400\u20131419.","journal-title":"J Med Chem"},{"issue":"4","key":"e_1_3_4_17_1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/cbdd.12508","article-title":"The synthesis and evaluation of C7-substituted \u03b1-tetralone derivatives as inhibitors of monoamine oxidase","volume":"86","author":"Legoabe LJ","year":"2015","unstructured":"Legoabe LJ, Petzer A, Petzer JP. The synthesis and evaluation of C7-substituted \u03b1-tetralone derivatives as inhibitors of monoamine oxidase. Chem Biol Drug Des. 2015;86(4):895\u2013904.","journal-title":"Chem Biol Drug Des"},{"issue":"12","key":"e_1_3_4_18_1","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.bmcl.2014.04.021","article-title":"\u03b1-Tetralone derivatives as inhibitors of monoamine oxidase","volume":"24","author":"Legoabe LJ","year":"2014","unstructured":"Legoabe LJ, Petzer A, Petzer JP. \u03b1-Tetralone derivatives as inhibitors of monoamine oxidase. Bioorg Med Chem Lett. 2014;24(12):2758\u20132763.","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1055\/s-0032-1323662","article-title":"The inhibition of monoamine oxidase by 8-(2-phenoxyethoxy)caffeine analogues","volume":"62","author":"Strydom B","year":"2012","unstructured":"Strydom B, Bergh JJ, Petzer JP. The inhibition of monoamine oxidase by 8-(2-phenoxyethoxy)caffeine analogues. Arzneimittelforschung. 2012;62(11):513\u2013518.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_4_20_1","doi-asserted-by":"crossref","unstructured":"He YF Li R. The summary of the synthesis of amines. Studies in Synthetic Chemistry. 2016;4(2):11\u201318.","DOI":"10.12677\/SSC.2016.42002"},{"issue":"8","key":"e_1_3_4_21_1","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1021\/acs.orglett.4c00229","article-title":"Carbazoquinocin analogues as small molecule biomimetic organocatalysts in dehydrogenative coupling of amines","volume":"26","author":"Kundu S","year":"2024","unstructured":"Kundu S, Ghosh C, Metya A, Banerjee A, Maji MS. Carbazoquinocin analogues as small molecule biomimetic organocatalysts in dehydrogenative coupling of amines. Org Lett. 2024;26(8):1705\u20131710.","journal-title":"Org Lett"},{"key":"e_1_3_4_22_1","unstructured":"Yu Y Feng J Wang Z. Preparation and application of a novel MAO-B inhibitor containing a tetrahydronaphthalen-1-amine structure: CN119285479A. 2025-01-10."},{"key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"103707","DOI":"10.1016\/j.bioorg.2020.103707","article-title":"Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson\u2019s disease","volume":"97","author":"Li W","year":"2020","unstructured":"Li W, Yang X, Song Q, Cao Z, Shi Y, Deng Y, Zhang L. Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson\u2019s disease. Bioorg Chem. 2020;97:103707.","journal-title":"Bioorg Chem"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-1-0716-3662-6_24","article-title":"Enzyme inhibition assays for monoamine oxidase","volume":"2761","author":"Mathew B","year":"2024","unstructured":"Mathew B, Oh JM, Parambi DGT, Sudevan ST, Kumar S, Kim H. Enzyme inhibition assays for monoamine oxidase. Methods Mol Biol. 2024;2761:329\u2013336.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/emboj\/cdg005","article-title":"Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site","volume":"22","author":"Bourne Y","year":"2003","unstructured":"Bourne Y, Taylor P, Radi\u0107 Z, Marchot P. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. Embo J. 2003;22(1):1\u201312.","journal-title":"Embo J"},{"key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"111770","DOI":"10.1016\/j.ejmech.2019.111770","article-title":"Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies","volume":"185","author":"Chavarria D","year":"2020","unstructured":"Chavarria D, Fernandes C, Silva V, Silva C, Gil-Martins E, Soares P, Silva T, Silva R, Remi\u00e3o F, Oliveira PJ, et al. Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies. Eur J Med Chem. 2020;185:111770.","journal-title":"Eur J Med Chem"},{"issue":"15","key":"e_1_3_4_27_1","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0710626105","article-title":"Structure of human monoamine oxidase A at 2.2-\u00c5 resolution: the control of opening the entry for substrates\/inhibitors","volume":"105","author":"Son S-Y","year":"2008","unstructured":"Son S-Y, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T. Structure of human monoamine oxidase A at 2.2-\u00c5 resolution: the control of opening the entry for substrates\/inhibitors. Proc Natl Acad Sci USA. 2008;105(15):5739\u20135744.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jm070677y","article-title":"Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs","volume":"50","author":"Binda C","year":"2007","unstructured":"Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem. 2007;50(23):5848\u20135852.","journal-title":"J Med Chem"},{"key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmech.2016.02.038","article-title":"Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors","volume":"114","author":"Hammuda A","year":"2016","unstructured":"Hammuda A, Shalaby R, Rovida S, Edmondson DE, Binda C, Khalil A. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors. Eur J Med Chem. 2016;114:162\u2013169.","journal-title":"Eur J Med Chem"},{"issue":"13","key":"e_1_3_4_30_1","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1074\/jbc.M006972200","article-title":"Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid","volume":"276","author":"Geha RM","year":"2001","unstructured":"Geha RM, Rebrin I, Chen K, Shih JC. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid. J Biol Chem. 2001;276(13):9877\u20139882.","journal-title":"J Biol Chem"},{"issue":"11","key":"e_1_3_4_31_1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","article-title":"What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery?","volume":"16","author":"Tuccinardi T.","year":"2021","unstructured":"Tuccinardi T. What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery? Expert Opin Drug Discov. 2021;16(11):1233\u20131237.","journal-title":"Expert Opin Drug Discov"},{"issue":"5","key":"e_1_3_4_32_1","first-page":"1603","article-title":"Molecular docking, MM-GBSA, and molecular dynamics approach: 5-MeO-DMT analogues as potential antidepressants","volume":"78","author":"Kalirajan R","year":"2023","unstructured":"Kalirajan R, Rishabh K, Srikanth J, Niharika M, Preeya N, Rezaul I. Molecular docking, MM-GBSA, and molecular dynamics approach: 5-MeO-DMT analogues as potential antidepressants. Arch Razi Inst. 2023;78(5):1603\u20131614.","journal-title":"Arch Razi Inst"},{"key":"e_1_3_4_33_1","doi-asserted-by":"crossref","first-page":"111916","DOI":"10.1016\/j.ejmech.2019.111916","article-title":"1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer\u2019s disease","volume":"187","author":"Wichur T","year":"2020","unstructured":"Wichur T, Wi\u0119ckowska A, Wi\u0119ckowski K, Gody\u0144 J, Jo\u0144czyk J, Valdivieso \u00c1DR, Panek D, Pasieka A, Sabat\u00e9 R, Knez D, et al. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer\u2019s disease. Eur J Med Chem. 2020;187:111916.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_4_34_1","doi-asserted-by":"crossref","first-page":"116074","DOI":"10.1016\/j.bmc.2021.116074","article-title":"Novel 3-benzylidene\/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"35","author":"Cao Z","year":"2021","unstructured":"Cao Z, Song Q, Yu G, Liu Z, Cong S, Tan Z, Deng Y. Novel 3-benzylidene\/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem. 2021;35:116074.","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tetlet.2010.10.128","article-title":"Palladium catalyzed synthesis of aryl thiols: sodium thiosulfate as a cheap and nontoxic mercapto surrogate","volume":"52","author":"Yi J","year":"2011","unstructured":"Yi J, Fu Y, Xiao B, Cui W-C, Guo Q-X. Palladium catalyzed synthesis of aryl thiols: sodium thiosulfate as a cheap and nontoxic mercapto surrogate. Tetrahedron Lett. 2011;52(2):205\u2013208.","journal-title":"Tetrahedron Lett"},{"issue":"9","key":"e_1_3_4_36_1","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00044-022-02932-9","article-title":"Triphenylpyrazoline ketone chlorophenols as potential candidate compounds against Parkinson\u2019s disease: design, synthesis, and biological evaluation","volume":"31","author":"Cheng NN","year":"2022","unstructured":"Cheng NN, Zhang LH, Ge R, Feng XE, Li QS. Triphenylpyrazoline ketone chlorophenols as potential candidate compounds against Parkinson\u2019s disease: design, synthesis, and biological evaluation. Med Chem Res. 2022;31(9):1517\u20131544.","journal-title":"Med Chem Res"},{"key":"e_1_3_4_37_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharmthera.2015.09.005","article-title":"Activation of endogenous antioxidants as a common therapeutic strategy against cancer, neurodegeneration and cardiovascular diseases: a lesson learnt from DJ-1","volume":"156","author":"Chan JY","year":"2015","unstructured":"Chan JY, Chan SH. Activation of endogenous antioxidants as a common therapeutic strategy against cancer, neurodegeneration and cardiovascular diseases: a lesson learnt from DJ-1. Pharmacol Ther. 2015;156:69\u201374.","journal-title":"Pharmacol Ther"},{"issue":"7","key":"e_1_3_4_38_1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1139\/cjpp-2014-0544","article-title":"Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes","volume":"93","author":"Sturza A","year":"2015","unstructured":"Sturza A, Duicu OM, Vaduva A, D\u0103nil\u0103 MD, Noveanu L, Varr\u00f3 A, Muntean DM. Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes. Can J Physiol Pharmacol. 2015;93(7):555\u2013561.","journal-title":"Can J Physiol Pharmacol"},{"key":"e_1_3_4_39_1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejmech.2019.05.039","article-title":"Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase","volume":"177","author":"Kumar B","year":"2019","unstructured":"Kumar B, Kumar V, Prashar V, Saini S, Dwivedi AR, Bajaj B, Mehta D, Parkash J, Kumar V. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase. Eur J Med Chem. 2019;177:221\u2013234.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_4_40_1","doi-asserted-by":"crossref","first-page":"128051","DOI":"10.1016\/j.bmcl.2021.128051","article-title":"Novel 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol derivatives as potent selective human monoamine oxidase B inhibitors: Design, SAR development, and biological evaluation","volume":"43","author":"Kong H","year":"2021","unstructured":"Kong H, Meng X, Hou R, Yang X, Han J, Xie Z, Duan Y, Liao C. Novel 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol derivatives as potent selective human monoamine oxidase B inhibitors: Design, SAR development, and biological evaluation. Bioorg Med Chem Lett. 2021;43:128051.","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"e_1_3_4_41_1","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1021\/acsomega.3c07703","article-title":"Design, synthesis, and biological effect studies of novel benzofuran-thiazolylhydrazone derivatives as monoamine oxidase inhibitors","volume":"9","author":"Osmani Ye D","year":"2024","unstructured":"Osmani Ye D, Sa\u011flik BN, Levent S, \u00c7evi K UA, Ilgin S, Yurtta\u015f L, \u00d6zkay Y, Karaburun AC, Kaplancikli ZA, Gundogdu-Karaburun N, et al. Design, synthesis, and biological effect studies of novel benzofuran-thiazolylhydrazone derivatives as monoamine oxidase inhibitors. ACS Omega. 2024;9(10):11388\u201311397.","journal-title":"ACS Omega"},{"issue":"1","key":"e_1_3_4_42_1","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina A","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.","journal-title":"Sci Rep"},{"key":"e_1_3_4_43_1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejmech.2019.06.041","article-title":"Carboxamides vs. methanimines: crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors","volume":"179","author":"Tzvetkov NT","year":"2019","unstructured":"Tzvetkov NT, Stammler H-G, Georgieva MG, Russo D, Faraone I, Balacheva AA, Hristova S, Atanasov AG, Milella L, Antonov L, et al. Carboxamides vs. methanimines: crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. Eur J Med Chem. 2019;179:404\u2013422.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_4_44_1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/js980402t","article-title":"Rapid calculation of polar molecular surface area and its application to predict transport phenomena. 2. Prediction of blood-brain barrier penetration","volume":"88","author":"Clark D E.","year":"1999","unstructured":"Clark D E., Clark, D. E. Rapid calculation of polar molecular surface area and its application to predict transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci. 1999;88:815\u2013821.","journal-title":"J Pharm Sci"},{"issue":"16","key":"e_1_3_4_45_1","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1021\/acs.jmedchem.7b00741","article-title":"Development of a mitochondriotropic antioxidant based on caffeic acid: proof of concept on cellular and mitochondrial oxidative stress models","volume":"60","author":"Teixeira J","year":"2017","unstructured":"Teixeira J, Cagide F, Benfeito S, Soares P, Garrido J, Baldeiras I, Ribeiro JA, Pereira CM, Silva AF, Andrade PB, et al. Development of a mitochondriotropic antioxidant based on caffeic acid: proof of concept on cellular and mitochondrial oxidative stress models. J Med Chem. 2017;60(16):7084\u20137098.","journal-title":"J Med Chem"},{"issue":"2","key":"e_1_3_4_46_1","article-title":"Fine-tuning the biological profile of multitarget mitochondriotropic antioxidants for neurodegenerative diseases","volume":"10","author":"Chavarria D","year":"2021","unstructured":"Chavarria D, Da Silva O, Benfeito S, Barreiro S, Garrido J, Cagide F, Soares P, Remi\u00e3o F, Brazzolotto X, Nachon F, et al. Fine-tuning the biological profile of multitarget mitochondriotropic antioxidants for neurodegenerative diseases. Antioxidants (Basel). 2021;10(2):329.","journal-title":"Antioxidants (Basel)"},{"issue":"14","key":"e_1_3_4_47_1","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1021\/acs.jmedchem.6b01469","article-title":"CNS physicochemical property space shaped by a diverse set of molecules with experimentally determined exposure in the mouse brain","volume":"60","author":"Rankovic Z.","year":"2017","unstructured":"Rankovic Z. CNS physicochemical property space shaped by a diverse set of molecules with experimentally determined exposure in the mouse brain. J Med Chem. 2017;60(14):5943\u20135954.","journal-title":"J Med Chem"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2025.2606434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:07:26Z","timestamp":1767877646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2025.2606434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2025.2606434"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2025.2606434","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2606434"}}